Patents by Inventor David Goldenberg

David Goldenberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020136690
    Abstract: A method of targeting a diagnostic or therapeutic agent to a focus of infection comprises injecting a patient infected with a pathogen parenterally with an antibody conjugate which specifically binds to an accessible epitope of the pathogen or of a pathogen-associated antigen accreted at the focus of infection, the antibody conjugate further comprising a bound diagnostic or therapeutic agent for detecting, imaging or treating the infection. Polyspecific composite conjugates enhance the efficacy of the method, which is especially useful for treating infections that are refractory towards systemic chemotherapy.
    Type: Application
    Filed: April 19, 2002
    Publication date: September 26, 2002
    Applicant: Immunomedics, Inc.
    Inventor: M. David Goldenberg
  • Patent number: 6387350
    Abstract: Methods are provided for close-range intraoperative, endoscopic and intravascular detection and treatment of lesions, including tumors and non-malignant lesions. The methods use antibody fragments or subfragments labeled with isotopic and non-isotopic agents. Also provided are methods for detection and treatment of lesions with photodynamic agents and methods of treating lesions with a protein conjugated to an agent capable of being activated to emit Auger electron or other ionizing radiation. Compositions and kits useful in the above methods are also provided.
    Type: Grant
    Filed: July 8, 1999
    Date of Patent: May 14, 2002
    Assignee: Immunomedics, Inc.
    Inventor: Milton David Goldenberg
  • Publication number: 20010055595
    Abstract: A method of targeting a diagnostic or therapeutic agent to a focus of infection comprises injecting a patient infected with a pathogen parenterally with an antibody conjugate which specifically binds to an accessible epitope of the pathogen or of a pathogen-associated antigen accreted at the focus of infection, the antibody conjugate further comprising a bound diagnostic or therapeutic agent for detecting, imaging or treating the infection. Polyspecific composite conjugates enhance the efficacy of the method, which is especially useful for treating infections that are refractory towards systemic chemotherapy.
    Type: Application
    Filed: August 24, 2001
    Publication date: December 27, 2001
    Inventor: M. David Goldenberg
  • Patent number: 6331175
    Abstract: Provided are methods and compositions for detecting and treating normal, hypoplastic, ectopic or remnant tissue, organ or cells in a mammal. The method comprises parenterally injecting a mammalian subject, at a locus and by a route providing access to above-mentioned tissue or organ, with an composition comprising antibody/fragment which specifically binds to targeted organ, tissue or cell. The antibody/fragment may be administered alone, or labeled or conjugated with an imaging, therapeutic, cytoprotective or activating agent.
    Type: Grant
    Filed: July 6, 1998
    Date of Patent: December 18, 2001
    Assignee: Immunomedics, Inc.
    Inventor: Milton David Goldenberg
  • Patent number: 6319500
    Abstract: A method of targeting a diagnostic or therapeutic agent to a focus of infection comprises injecting a patient infected with a pathogen parenterally with an antibody conjugate which specifically binds to an accessible epitope of the pathogen or of a pathogen-associated antigen accreted at the focus of infection, the antibody conjugate further comprising a bound diagnostic or therapeutic agent for detecting, imaging or treating the infection. Polyspecific composite conjugates enhance the efficacy of the method, which is especially useful for treating infections that are refractory towards systemic chemotherapy.
    Type: Grant
    Filed: December 1, 1993
    Date of Patent: November 20, 2001
    Assignee: Immunomedics, Inc.
    Inventor: M. David Goldenberg
  • Publication number: 20010006618
    Abstract: Methods are provided for close-range intraoperative, endoscopic and intravascular detection and treatment of lesions, including tumors and non-malignant lesions. The methods use antibody fragments or subfragments labeled with isotopic and non-isotopic agents. Also provided are methods for detection and treatment of lesions with photodynamic agents and methods of treating lesions with a protein conjugated to an agent capable of being activated to emit Auger electron or other ionizing radiation. Compositions and kits useful in the above methods are also provided.
    Type: Application
    Filed: July 8, 1999
    Publication date: July 5, 2001
    Inventor: MILTON DAVID GOLDENBERG
  • Patent number: 6096289
    Abstract: Methods are provided for close-range intraoperative, endoscopic and intravascular deflection and treatment of lesions, including tumors and non-malignant lesions. The methods use antibody fragments or subfragments labeled with isotopic and non-isotopic agents. Also provided are methods for detection and treatment of lesions with photodynamic agents and methods of treating lesions with a protein conjugated to an agent capable of being activated to emit Auger electron or other ionizing radiation. Compositions and kits useful in the above methods are also provided.
    Type: Grant
    Filed: February 10, 1998
    Date of Patent: August 1, 2000
    Assignee: Immunomedics, Inc.
    Inventor: Milton David Goldenberg
  • Patent number: 5983459
    Abstract: A clip for securing eyeglasses or sunglasses that slides onto an article of clothing. The clip has two parts integrally formed together and kept in a folded position by a spring. The two parts contact each other near the free ends, similar to a conventional money clip. The outer face of one part of the clip has an elastic material stretched across its width to create a channel for receiving an earpiece of a pair of eyeglasses or sunglasses. The exterior face of the other part of the clip has a forked protrusion, in which the space between forks is approximately equal to the width of an earpiece of a conventional pair of eyeglasses or sunglasses. In use, a piece of clothing is slid between the two parts of the clip. A pair of eyeglasses or sunglasses is mounted on the clip by first sliding one earpiece through the channel formed by the elastic material, and then snapping the other earpiece between the forks of the protrusion on the other side.
    Type: Grant
    Filed: June 16, 1998
    Date of Patent: November 16, 1999
    Inventor: David Goldenberg
  • Patent number: 5843397
    Abstract: Anticancer, antimicrobial and autoimmune disease, and anti-organ rejection therapy using cytotoxic agents is improved using cytokines to prevent, mitigate or reverse adverse radiation-induced or drug-induced toxicity, especially to hematopoietic cells. Cytotoxic agents can include radioisotopes, drugs, toxins and even unconjugated cytotoxic antibodies. A preferred cytokine is IL-1. Higher doses of cytotoxic agents can be administered and tolerated by the patient and dose-limiting marrow toxicity can be prevented, palliated or reversed using adjunct cytokine therapy.
    Type: Grant
    Filed: February 18, 1997
    Date of Patent: December 1, 1998
    Assignee: Immunomedics, Inc.
    Inventor: Milton David Goldenberg
  • Patent number: 5776095
    Abstract: Provided are methods and compositions for detecting and treating normal, hypoplastic, ectopic or remnant tissue, organ or cells in a mammal. The method comprises parenterally injecting a mammalian subject, at a locus and by a route providing access to said tissue or organ, with an composition comprising antibody/fragment which specifically binds to targeted organ, tissue or cell. The antibody/fragment may be administered alone, or labeled or conjugated with an imaging, therapeutic, cytoprotective or activating agent.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: July 7, 1998
    Assignee: Immunomedics, Inc.
    Inventor: Milton David Goldenberg
  • Patent number: 5776094
    Abstract: Provided are methods and compositions for detecting and treating normal, hypoplastic, ectopic or remnant tissue, organ or cells in a mammal. The method comprises parenterally injecting a mammalian subject, at a locus and by a route providing access to said tissue or organ, with an composition comprising antibody/fragment which specifically binds to targeted organ, tissue or cell. The antibody/fragment may be administered alone, or labeled or conjugated with an imaging, therapeutic, cytoprotective or activating agent.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: July 7, 1998
    Assignee: Immunomedics, Inc.
    Inventor: Milton David Goldenberg
  • Patent number: 5776093
    Abstract: Provided are methods and compositions for detecting and treating normal, hypoplastic, ectopic or remnant tissue, organ or cells in a mammal. The method comprises parenterally injecting a mammalian subject, at a locus and by a route providing access to said tissue or organ, with an composition comprising antibody/fragment which specifically binds to targeted organ, tissue or cell. The antibody/fragment may be administered alone, or labeled or conjugated with an imaging, therapeutic, cytoprotective or activating agent.
    Type: Grant
    Filed: April 7, 1992
    Date of Patent: July 7, 1998
    Assignee: Immunomedics, Inc.
    Inventor: Milton David Goldenberg
  • Patent number: 5705158
    Abstract: A polyspecific anti-leukocyte antibody conjugate for targeting foci of leukocyte accretion comprises an immunoreactive polyspecific composite of at least two different substantially monospecific antibodies or antibody fragments, conjugated to at least one imaging agent, wherein at least two of said antibodies or antibody fragments specifically bind to different leukocyte cell types.A method for targeting an imaging agent to an inflammatory or infectious lesion comprises injecting a mammal parenterally with an effective amount for targeting of the above anti-leukocyte imaging conjugate.A therapeutic anti-leukocyte antibody-agent conjugate for targeting foci of leukocyte accretion comprises at least one immunoreactive substantially monospecific antibody or antibody fragment which specifically binds to at least one leukocyte cell type, conjugated to at least one therapeutic antimicrobial agent.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 6, 1998
    Assignee: Immunomedics, Inc.
    Inventors: Hans John Hansen, Milton David Goldenberg
  • Patent number: 5697902
    Abstract: Provided are methods and compositions for detecting and treating normal, hypoplastic, ectopic or remnant tissue, organ or cells in a mammal. The method comprises parenterally injecting a mammalian subject, at a locus and by a route providing access to said tissue or organ, with an composition comprising antibody/fragment which specifically binds to targeted organ, tissue or cell. The antibody/fragment may be administered alone, or labeled or conjugated with an imaging, therapeutic, cytoprotective or activating agent.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: December 16, 1997
    Assignee: Immunomedics, Inc.
    Inventor: Milton David Goldenberg
  • Patent number: 5332567
    Abstract: A method of targeting a diagnostic or therapeutic agent to a focus of infection comprises injecting a patient infected with a pathogen parenterally with an antibody conjugate which specifically binds to an accessible epitope of the pathogen or of a pathogen-associated antigen accreted at the focus of infection, the antibody conjugate further comprising a bound diagnostic or therapeutic agent for detecting, imaging or treating the infection. Polyspecific composite conjugates enhance the efficacy of the method, which is especially useful for treating infections that are refractory towards systemic chemotherapy.
    Type: Grant
    Filed: March 22, 1993
    Date of Patent: July 26, 1994
    Assignee: Immunomedics
    Inventor: M. David Goldenberg
  • Patent number: 4460561
    Abstract: Methods are provided for using radiolabeled antibodies specific to intracellular tumor-associated markers for detection, localization and therapy of tumors. Injectable compositions for use in the methods of the invention are also provided.
    Type: Grant
    Filed: September 8, 1982
    Date of Patent: July 17, 1984
    Inventor: M. David Goldenberg
  • Patent number: 4215373
    Abstract: A device for projecting and magnifying a picture image from a television set. A first housing is removably mounted to the television set to receive the picture image from the television screen. A second housing is slidably mounted to the first housing and cooperatively with the first housing forms a passage through which the picture image passes to a lens mounted at the end of the second housing. The first housing includes a light-absorbent inner surface whereas the second housing includes a light-reflective inner surface. A gear and rack device is provided for slidably adjusting the second housing relative to the first housing and controlling the ratio of the light-reflective surface to the light-absorbent surface. A barrel-configured lens is slidably mounted to the second housing for focusing of the picture image on a remotely located viewing surface which may be positioned at any one of a number of different distances from the television set and lens.
    Type: Grant
    Filed: October 19, 1978
    Date of Patent: July 29, 1980
    Inventors: Max Goldenberg, David A. Goldenberg